Bone Structure and Function • The physical and chemical properties of bone relate to its three main functions: • provision of support • protection • calcium homeostasis Macroscopically, there are two types of bone: • dense cortical bone • spongy cancellous bone Bone Structure and Function • Cortical bone is located in the diaphyses of long bones and on the surfaces of flat bones. There is also a thin cortical shell at the epiphyses and metaphyses of long bones. • Trabecular bone is limited to the epiphyseal and metaphyseal regions of long bones and is present within the cortical coverings in the smaller flat and short bones. Osso trabecolare Osso corticale Osso trabecolare Bone Structure and Function The difference between cortical bone and trabecular bone is both structural and functional. The structural differences are essentially quantitative: 80-90% of the volume of compact bone is calcified vs. 15-25% in trabecular bone (the remaining volume is occupied by the marrow) Cortical bone fulfils mainly (but not exclusively) a mechanical and protective function and the trabecular bone a metabolic function. Bone Structure and Function Bone turnover is mediated by coupling of the bone-forming cellular activity of osteoblasts and the boneresorbing osteoclasts. Bone Structure and Function The osteoblast is the bone cell responsible for the production of the matrix constituents (collagen and ground substance). It also plays an important part in the calcification process. It originates from a local mesenchymal stem cell (bone marrow stromal stem cell or connective tissue mesenchymal cell). Bone Structure and Function The osteoclast is the bone cell responsible for bone resorption. It is a giant multinucleated cell (4-20 nuclei) Its progenitor is related to the monocyte-macrophage family. Bone Structure and Function Where the bone is in contact with the soft tissues is an external surface (periosteal) and where the bone is in contact with the bone marrow an internal surface (endosteal). These surfaces are lined with osteogenic cells organized in layers termed the periosteum and endosteum, respectively. The Remodeling Cycle on a Trabecula The activity of bone cells along the surfaces of bone, mainly the endosteal surface, results in bone remodeling. This is the process by which bone grows and is turned over. N Engl J Med 2006;354;21 Osteoporosis The most common type of metabolic bone disease. Parallel reduction in bone mineral and bone matrix. The bone is decreased in amount but is of normal composition. The strength of bone is reduced and the risk of fracture is increased. Normal bone Osteoporosis Osteoporosis Primary osteoporosis: reduced bone mass and fractures in postmenopausal women (type I, or ‘postmenopausal’ osteoporosis) or in older men and women due to age-related factors (type II osteoporosis). Secondary osteoporosis: bone loss resulting from specific clinical disorders, such as thyrotoxicosis or hyperadrenocorticism. Tipi di osteoporosi primaria Tipo I Postmenopausale Tipo II Senile Età (anni) 50-70 >70 Osso interessato Principalmente trabecolare Trabecolare e corticale Sedi di frattura Vertebre Radio (Colles) Femore prossimale Causa principale Menopausa Invecchiamento Osteoporosis Osteoporosis affects over 20 million Americans and leads to approximately 1.5 million fractures in the United States each year. During the course of their lifetime, women lose about 50% of their trabecular bone and 30% of their cortical bone. About 40% of all postmenopausal white women eventually sustain osteoporotic fractures. By extreme old age, one third of all women and one sixth of all men will have a hip fracture. Osteoporosis At any age, women experience twice as many osteoporosis-related fractures as men, reflecting gender-related differences in skeletal properties as well as the almost universal loss of bone at menopause. However, osteoporotic fractures in older men should not be considered trivial. Osteoporosis Osteoporotic fractures are a major public health problem for older women and men in Western society. Half the men and women over age 55 have low bone mass or osteoporosis, placing them at increased risk of fracture. Incidence of osteoporotic fractures in men Incidence of osteoporotic fractures in women Osteoporosis One white woman in six suffers a hip fracture; mortality after hip fracture ranges from 12–20% in the first year. One-third of hip fractures occur in men and have been associated with an even higher mortality rate than in women. Billions of dollars are spent annually for acute hospital care of hip fracture alone. Osteoporosis The consequences of vertebral deformity are also significant and include chronic pain, inability to conduct daily activities, depression, and high risk of further vertebral fractures. Peak bone mass The amount of bone mineral present at any time in adult life represents that which has been gained at skeletal maturity (peak bone mass) minus that which has been subsequently lost. Bone acquisition is completed in the late teenage years and early twenties in girls and by the second decade in boys. At any point in time, bone density in adults depends on both the peak bone density achieved during development and the subsequent bone loss. Thus, osteopenia can result from deficient pubertal bone accretion, accelerated adult bone loss, or both. Factors that may affect peak bone mass Gender Race Genetic factors Gonadal steroids Growth hormone Timing of puberty Calcium intake Exercise Other disorders associated with reduced peak bone mass Anorexia nervosa Ankylosing spondylitis Childhood immobilization (‘therapeutic bed rest’) Cystic fibrosis Delayed puberty Exercise-associated amenorrhea Galactosemia Intestinal or renal disease Marfan's syndrome Osteogenesis imperfecta Serum estradiol concentrations risk of subsequent hip or vertebral fracture in postmenopausal women Regulation of osteoclast development RANKL: Receptor Activator of Nuclear factor-κB Ligand OPG: osteoprotegerin (decoy receptor) Causes of osteoporosis according to probable mechanism High turnover (increased bone resorption greater than increased bone formation) • Estrogen deficiency - primarily in postmenopausal women • Hyperparathyroidism • Hyperthyroidism • Hypogonadism in young women and in men • Cyclosporine (?) • Heparin Causes of osteoporosis according to probable mechanism Low turnover (decreased bone formation more pronounced than decreased bone resorption) • Liver disease – primarily primary biliary cirrhosis • Heparin • Age above 50 years Increased bone resorption and decreased bone formation • Glucocorticoids Diseases associated with secondary osteoporosis Endocrine diseases Hypogonadism Hyperparathyroidism Hyperthyroidism Hypercortisolism Hyperprolactinemia Diabetes mellitus, type I Gastrointestinal diseases Inflammatory bowel disease Malabsorption syndromes Celiac disease Chronic liver disease Gastric bypass operations Diseases associated with secondary osteoporosis Other chronic diseases Chronic rheumatic disorders Rheumatoid arthritis Ankylosing spondylitis Chronic obstructive pulmonary disease Renal disorders Renal tubular acidosis Idiopathic hypercalciuria Malignancy Multiple myeloma Metastatic disease Infiltrative disorders Systemic mastocytosis Hereditary disorders of connective tissue Osteogenesis imperfecta Diseases associated with secondary osteoporosis Organ transplantation Dietary disorders Vitamin D deficiency and insufficiency Calcium deficiency Excessive alcohol intake Anorexia nervosa Total parenteral nutrition <> Frattura di Colles Frattura del collo del femore Mineralometria ossea computerizzata Mineralometria ossea computerizzata DEXA: Dual Energy X-ray Absorptiometry The T score is the number of standard deviations by which the patient's bone density differs from the peak bone density of individuals of the same gender and ethnicity. The Z score is the number of standard deviations by which the patient's bone density differs from bone density of age-matched individuals of the same gender and ethnicity. Diagnostic categories for osteopenia and osteoporosis based upon bone mass measurements Normal A value for bone mineral density (BMD) or bone mineral content (BMC) within one standard deviation of the young adult reference mean. Low bone mass (osteopenia) A value for BMD or BMC more than one and less than 2.5 standard deviations below the young adult reference mean. Osteoporosis A value for BMD or BMC more than 2.5 standard deviations below the young adult reference meanSevere (established) osteoporosisA value for BMD or BMC more than 2.5 standard deviations below the young adult reference mean in the presence of one or more fragility fractures. Biochemical Markers of Bone Metabolism in Clinical Use Bone formation Serum bone-specific alkaline phosphatase Serum osteocalcin Serum propeptide of type I procollagen Bone resorption Urine and serum cross-linked N-telopeptide Urine and serum cross-linked C-telopeptide Urine total free deoxypyridinoline Urine hydroxyproline Serum tartrate-resistant acid phosphatase Serum bone sialoprotein Urine hydroxylysine glycosides Risk Factors for Osteoporosis Fracture Nonmodifiable • • • • • • Personal history of fracture as an adult History of fracture in first-degree relative Female sex Advanced age Caucasian race Dementia Risk Factors for Osteoporosis Fracture Potentially modifiable • Current cigarette smoking • Low body weight [<58 kg) • Estrogen deficiency • Early menopause (<45 years) or bilateral ovariectomy • Prolonged premenstrual amenorrhea (>1 year) • Low calcium intake • Alcoholism • Impaired eyesight despite adequate correction • Recurrent falls • Inadequate physical activity • Poor health/frailty • Osteoporosis means increased bony fragility and is clinically defined as reduced bone mass (osteopenia) to an extent sufficient to result in fracture with minimal trauma. • Osteoporosis is the most common disease that affects bone. Fractures are not usually manifest until patients have bone mass 30-40% below normal values. • Osteoporosis is a multifactorial disease and not solely the inevitable consequence of aging. • Osteoporotic fractures are most frequent in the spine, the hip and wrist but virtually any bone can be affected. • Osteoporosis is more common in women than in men, but is an increasing public health problem in both sexes in aging populations. • One third of women over the age of 65 will have vertebral fractures, and the life-time risk of hip fracture in Caucasian women is 16% and in men 5%. • Osteoporosis is associated with high morbidity and, in the case of hip fracture, increased mortality. • Osteoporosis is of considerable socioeconomic importance because of the high prevalence of fracture and the enormous costs in health care required to deal with the consequences of these fractures. • Osteoporosis can be prevented in patients at risk by maximizing peak bone mass and prevention of major bone loss. Therapies are also available for restoration of bone mass in those patients with existing bone loss. Osteomalacia Defective skeletal mineralization in adults Osteomalacia: symptoms and signs • Vitamin D deficiency • Dietary calcium deficiency • Phosphate deficiency • Oncogenic osteomalacia • Fibrogenesis imperfecta Osteomalacia: essentials of diagnosis Bone pain and tenderness Decreased bone density Increased alkaline phosphatase Decreased 25(OH)D3 Osteomalacia: symptoms and signs Initially asymptomatic Eventually, bone pain, simulating fibromyalgia Painful proximal muscle weakness (especially pelvic girdle) due to calcium deficiency Fractures with little or no trauma Looser-Milkman pseudofractures The primary source of vitamin D in humans is photoactivation. Osteomalacia: laboratory tests Alkaline phosphatase (age-adjusted) may be elevated 25(OH)D3 typically low < 20 ng/mL (< 50 nmol/L) Calcium or phosphate (age-adjusted) may be low Phosphate low in 47% Parathyroid hormone may be increased due to secondary hyperparathyroidism Urinary calcium may be low 1,25(OH)2D3 may be low Screen for hypophosphatasia